±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1808  |  »Ø¸´: 7
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

liying841216

½ð³æ (³õÈëÎÄ̳)

[ÇóÖú] 300½ð±ÒÇóÖú·­ÒëС˶ÂÛÎÄÕªÒª

±³¾°ÓëÄ¿µÄ£ºÊµÑéͨ¹ý½¨Á¢Ä£ÄâÈËÆ¤·ôÈ¡Æ¤Çø´´ÃæÀ´¼ì²âÉú³¤Òò×ÓTGF-¦Â1ºÍVEGFÔÚ´´ÃæÓúºÏÒÔ¼°ñ£ºÛÔöÉú·½ÃæµÄ×÷Óã¬ÎªÁÙ´²Ó¦ÓÃÐÂÐÍÔåËáÑηóÁÏÖÎÁÆÈ¡Æ¤Çø´´ÃæµÄÓ¦ÓÃÌṩÊý¾ÝÒÀ¾Ý£¬·½·¨£ºÖ÷Òª½«ÔåËáÑηóÁÏÓ¦ÓÃÓÚ°æÄÉ΢ÐÍÖí½ü½»ÏµÖкñÆ¤È¡Æ¤Çø´´Ã棬ͨ¹ý¼ì²â²»Í¬Ê±¼äµã£¨È¡Æ¤ºó0¡¢3¡¢7¡¢14¡¢28Ì죩´´ÃæÓúºÏ¹ý³ÌÖм°´´ÃæÓúºÏºóµÄÉú³¤Òò×ÓTGF-¦Â1¡¢VEGFµÄmRNA±í´ïÇé¿ö£¬Ì½ÌÖÐÂÐÍÔåËáÑηóÁ϶Դ´ÃæÓúºÏµÄÉúÎïѧ»úÖÆ¼°¼õÇáñ£ºÛÔöÉúµÄ¾ßÌå×÷ÓûúÖÆ¡£½á¹û£º¹¹½¨µÄÈ¡Æ¤Çø´´Ã涯ÎïÄ£ÐÍ£¬´Ó´óÌåÍâ¹ÛÉϹ۲⣬ÆäÔåËáÑÎÖÎÁÆ×éÓ뷲ʿÁÖ¶ÔÕÕ×é´æÔÚÃ÷ÏÔ²îÒ죬ÖÎÁÆ×é´´ÃæÓúºÏʱ¼äÉÙÓÚ¶ÔÕÕ×é(P<0.05),¾ßÓÐͳ¼ÆÑ§²îÒì¡£È¡Æ¤Çø´´ÃæÓúºÏ¹ý³ÌÖв»Í¬Ê±¼äµãµÄÖÎÁÆ×éÓë¶ÔÕÕ×éµÄ»ùÒò±í´ïÇé¿ö±íÃ÷£¬²»Í¬µÄʱ¼äµãÖ®¼äÓÐÏÔÖø²îÒ죨P£¼0.01£©£¬ÖÎÁÆÓë·ñÓÐÏÔÖøÐÔ²îÒ죨P£½0.025£©£¬²»Í¬ÖíÖ®¼äÎÞͳ¼ÆÑ§²îÒì¡£TGF-¦Â1ÔÚ0¡¢3¡¢7¡¢14¡¢28ÌìµÄ±í´ïÁ¿Îª£ºÖÎÁÆ×é-5.068¡À0.286£¬-4.131¡À0.396£¬-3.294¡À0.516£¬-3.514¡À0.374£¬-4.695¡À0.809£»¶ÔÕÕ×é-5.068¡À0.286£¬-4,457¡À0.450£¬-4.262¡À0.512£¬-4.025¡À0.365£¬-4.485¡À0.233¡£TGF-¦Â1±íÏÖÎªËæ×Å´´ÃæµÄÓúºÏÆä±í´ïÉÏÉý£¬ÖÁÖÐÆÚ±í´ïÉýÖÁ×î¸ß£¬Ö®ºó±í´ïϽµ£¬ÔÚ´´ÃæÍêÈ«ÓúºÏºóÆä±í´ïÁ¿Ç÷ÓÚÕý³£Ë®Æ½¡£ÆäÖÐÔÚ14ÌìÔåËáÑÎÖÎÁÆ×éÓ뷲ʿÁÖ¶ÔÕÕ×éÖ®¼äTGF-¦Â1±í´ïÓÐÏÔÖø²îÒì¡£VEGFµÄmRNA±í´ïÁ¿µÄͳ¼Æ½á¹ûÓëTGF-¦Â1µÄ½á¹ûÏàËÆ£¬ÆäÖÐ7ÌìÔåËáÑÎÖÎÁÆ×éÓ뷲ʿÁÖ¶ÔÕÕ×éÖ®¼äVEGFµÄmRNAµÄ±í´ïÓÐÏÔÖø²îÒì¡£VEGFÔÚ0¡¢3¡¢7¡¢14¡¢28ÌìµÄ±í´ïÁ¿Îª£ºÖÎÁÆ×é-3.461¡À0.279,-2.726¡À0.425,-1.722¡À0.097,-2.401¡À0.341,-2.902¡À0.437,¶ÔÕÕ×éΪ-2.928¡À0.385£¬-2.522¡À0.319£¬-2.877¡À0.517£¬-3.230¡À0.451¡£½áÂÛ£ºÍ¨¹ý¹¹½¨È¡Æ¤ºóÖкñƤ´´Ã涯ÎïÄ£ÐÍ£¬³É¹¦¹¹½¨Á˼ì²âÈ¡Æ¤Çø´´Ãæ×éÖ¯ÖÐVEGF¡¢TGF-¦Â1µÄmRNAµÄSYBR Green¢ñʵʱӫ¹â¶¨Á¿¼ì²â·½·¨£¬½ÒʾÔåËáÑηóÁ϶Դٽø´´ÃæÓúºÏÓÐÖØÒª×÷Óã¬ÇÒÖ÷ÒªÓëµ÷¿ØÏ¸°ûÒò×ӵıí´ïÏà¹Ø£¬Îª½â¾ö´´ÃæÓúºÏ¼õÉÙñ£ºÛÔöÉúµÈÁÙ´²¼¬ÊÖÎÊÌâÌṩÁ˿ɿ¿µÄÀíÂÛÒÀ¾Ý¡£

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

sll6658110

Í­³æ (³õÈëÎÄ̳)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï
ringzhu(½ð±Ò-5): ±¾°æÑϽû»úÆ÷·­Ò룡£¡Ó¦ÖúǰÇë×ÐϸÔĶÁ±¾°æ°æ¹æ~~¶àлºÏ×÷ 2011-04-28 18:44:31
Background and purpose: experiments to simulate the skin by establishing take skin area to detect growth factor wound TGF - beta 1 and VEGF in wound healing and the role of scar tissue hyperplasia for clinical application, new alginate dressings treatment take skin area wound applied to provide data basis, methods: main will alginate dressing applied in miniature pig with coefficient of thick skin take skin area through testing the tissue, at different time points (0, 3 after take skin, 7, 14 and 28 days) coagulant process and the growth factor coagulant TGF - beta 1, VEGF, discusses the mRNA expression of new alginate dressing coagulant biological mechanism and reduce the specific mechanism scar hyperplasia. Results: the construction of animal model take skin area wound from the gross appearance on alginate observation, the treatment group and control group vaseline, there exists significant difference in treatment group wound healing time less than in control group (P < 0.05), has a statistically significant. Take skin area coagulant at different time points in the process of the treatment group and control group, gene expression in different time points that there was a significant difference between (P < 0.01), treatment or not have significant difference (P = 0.025), between different pig was not statistically significant. TGF - beta 1 at 0, 3, 7, 14 and 28 days of express quantity is: treatment group - 5.068 + 4.131 + 0.396 0.286, - 0.516, 3.294 +, - 0.374 3.514 +, - - 4.695 + 0.809; 5.068 + 0.286 group - 0.450 4,457 +, - 0.512, 4.262 +, - 0.365 4.025 +, - - 4.485 + 0.233. TGF - beta 1 performance as the healing of the wound up its expression, to medium express to its hi
8Â¥2011-04-25 18:04:40
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 8 ¸ö»Ø´ð

zhenghuadong

ľ³æ (ÖøÃûдÊÖ)

Çڷܵijæ×Ó

½¨ÒéÂ¥Ö÷×Ô¼º·­ÒëÏ¿©£¬¿ÉÒÔ¶ÍÁ¶Ó¢Óïˮƽ°¡
bluenote
2Â¥2011-04-20 18:07:34
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

fxd_1988

½ð³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ...
ringzhu(½ð±Ò+2): »¶Ó­³£À´·­Òë°æ~~ 2011-04-21 20:27:38
ringzhu(½ð±Ò+50, ·­ÒëEPI+1): »¶Ó­³£À´~~ 2011-04-28 18:46:48
ringzhu(½ð±Ò+50): 2011-04-28 18:46:55
ringzhu(½ð±Ò+50): 2011-04-28 18:47:00
Background and Objective£ºwe detect the influence of growth factor  TGF-¦Â1 and VEGF in wound healing and scar formation through the establishment of simulation of people skin in access site wound. it provides the data for clinical application of new alginate dressings on skin treatment Wounds .
Method:we mainly applied alginate dressing in inbred Banna minipig check site wounds in the thick. we detect the different time points (0,3,7,14,28 days after taking the skin) and wound healing process of wound healing growth factor TGF-¦Â1, VEGF expression of the mRNA to explore new alginate dressing on wound healing biological mechanisms and the specific role of reducing scar formation mechanism.
³ÔÍêÖз¹»ØÀ´¼ÌÐø·­
3Â¥2011-04-21 11:14:49
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

fxd_1988

½ð³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
ringzhu(½ð±Ò+50): 2011-04-28 18:46:28
Results: we observe from the general appearance of construction of access site wound model, , the Vaseline alginate treatment group and control group was significantly different, healing time  of the treatment group was shorter than the control group (P <0.05), which is significantly different. Skin graft taken at different time points during the treatment and control groups showed that the gene expression of the different time points were significantly different(P <0.01), whether the treatment significantly different or not (P = 0.025), no statistical difference between the different pigs exists.
4Â¥2011-04-21 11:22:13
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ¿¼Ñе÷¼Á +5 ÃÀÀöµÄyouth_ 2026-04-04 6/300 2026-04-06 06:57 by houyaoxu
[¿¼ÑÐ] 302·Ö 085601Çóµ÷¼ÁÍÆ¼ö +11 zyxÉϰ¶£¡ 2026-04-05 11/550 2026-04-05 22:13 by dongzh2009
[¿¼ÑÐ] 086000ÉúÎïÓëÒ½Ò©298µ÷¼ÁÇóÖú +9 ÔªÔªÇàÇà 2026-03-31 12/600 2026-04-05 21:03 by ѧԱ8dgXkO
[¿¼ÑÐ] ²ÄÁÏר˶(0856) 339·ÖÇóµ÷¼Á +10 ¹þ¹þ¹þ¶ì¹þ¹þ¹þ 2026-04-04 10/500 2026-04-05 18:51 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 285Çóµ÷¼Á +11 ŶßϺôo 2026-04-04 11/550 2026-04-05 17:59 by Öí»á·É
[¿¼ÑÐ] 306·Ö²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +7 Àè°ÉÀ²À²ÄãºÜÓÐà 2026-04-03 7/350 2026-04-05 17:18 by Hdyxbekcb
[¿¼ÑÐ] ÉúÎ﹤³ÌÇóµ÷¼Á +6 ϲ»¶»¹ÊDz»¸ÊÐÄ 2026-04-05 6/300 2026-04-05 10:28 by ÌÆãå¶ù
[¿¼ÑÐ] ±¾¿Æ211 ·ÖÊý293ÇëÇóµ÷¼Á +4 Á«²Ë¾ÍÊÇź°É 2026-04-01 4/200 2026-04-04 22:32 by hemengdong
[¿¼ÑÐ] Ò»Ö¾Ô¸ÉϺ£´óѧÉúÎïѧ346 +3 ÉϺ£´óѧ346µ÷¼Á 2026-04-03 3/150 2026-04-04 20:20 by dongzh2009
[ÂÛÎÄͶ¸å] ÇóÎÄÏ× 5+3 ys879651$ 2026-04-02 3/150 2026-04-04 17:22 by bobvan
[¿¼ÑÐ] 303Çóµ÷¼Á +3 һɫÇåÓð 2026-04-02 4/200 2026-04-03 10:22 by À¶ÔÆË¼Óê
[¿¼ÑÐ] Ò»Ö¾Ô¸ÏÃÃÅ´óѧ²ÄÁϹ¤³Ìר˶354ÕÒµ÷¼Á£¡£¡£¡ +8 ±´ß±µ±µ 2026-03-30 8/400 2026-04-03 09:41 by hypershenger
[¿¼ÑÐ] 085600£¬320·ÖÇóµ÷¼Á +6 ´ó²öС×Ó 2026-04-02 6/300 2026-04-02 21:54 by dongzh2009
[¿¼ÑÐ] Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358 +3 cs0106 2026-04-02 5/250 2026-04-02 11:37 by olim
[¿¼ÑÐ] 0710ÉúÎïѧÇóµ÷¼Á +9 manman511 2026-04-01 9/450 2026-04-02 10:00 by zxl830724
[¿¼²©] 26ÄêÉ격 +3 staryer 2026-03-30 4/200 2026-04-01 23:21 by ai4pharm
[¿¼ÑÐ] 0703Ò»Ö¾Ô¸ÄÏʦ´ó334Çóµ÷¼Á +4 seven7yu 2026-03-30 4/200 2026-04-01 16:10 by oooqiao
[¿¼ÑÐ] 311Çóµ÷¼Á +10 ÀîÜÆÐÂ1 2026-03-31 10/500 2026-04-01 14:38 by chenqifeng666
[¿¼ÑÐ] 0855»úе³õÊÔ280Çóµ÷¼Á +3 kazenotori 2026-03-31 3/150 2026-04-01 10:08 by JourneyLucky
[¿¼ÑÐ] 313Çóµ÷¼Á +6 Âô¸ö¹Ø×Ó°É 2026-03-31 6/300 2026-03-31 10:58 by Jaylen.
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û